Entrada Therapeutics (TRDA) Stock Price & Financial Analysis
Entrada Therapeutics Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About Entrada Therapeutics
What is the current stock price for TRDA?
As of the latest trading session, TRDA stock trades at $6.04. The 52-week range is $4.93–$16.45, with a day range of $5.70–$6.07.
What is the P/E ratio for TRDA?
The P/E ratio (Price-to-Earnings) for TRDA is shown in the Key Statistics section. This valuation metric helps compare Entrada Therapeutics, Inc. to industry peers.
Does TRDA pay dividends?
Entrada Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for TRDA?
Based on 4 analysts, the consensus for TRDA is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.
What is the market cap of TRDA?
Entrada Therapeutics's market capitalization is $249.9M, classifying it as a micro-cap company. Entrada Therapeutics operates in the Healthcare sector within the Biotechnology industry.